Cocktails of 2 mAbs based products are better equipped to deal with variants than single mAb based products which have a tendency of losing their efficacy with rapidly generating variants
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
Iberdomide has the potential to be the first approved CELMoD agent
Over a two-decade career, Dr. Berman has worked on more than a dozen clinical-stage immunotherapies, including senior leadership roles in developing four oncology biologics
CHOMax integrates cell line development, process development, analytics, and GMP manufacturing under robust quality processes
The grant will fund ten new J.MD projects over the next three years, targeting multiple global health threats
Subscribe To Our Newsletter & Stay Updated
